Weill Cornell Sandra & Edward Meyer Cancer Center | Strategic Alliance Partners

Latest from Weill Cornell Sandra & Edward Meyer Cancer Center


ASCO GI 2021 News

January 16, 2021

OncLive® will be LIVE with OncLive® News Network: On Location at the virtual 2021 ASCO GI. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented in gastrointestinal cancer during the virtual conference.

Oncolytic Viral Therapy: A Unique Approach to Explore in GI Cancers

December 11, 2020

December 11, 2020 - Oncolytic viral therapy has been heavily investigated across oncology, but plenty of work still lies ahead to determine how this treatment approach can be applied in gastrointestinal malignancies.

Dr. Ruan on Treatment Considerations for Relapsed/Refractory MCL

November 30, 2020

Jia Ruan, MD, PhD, associate professor of clinical medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses treatment considerations for patients with relapsed/refractory mantle cell lymphoma.

x